Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWroclaw Medical University

About this trial

Heart failure (HF) is a chronic and progressive condition that significantly affects patients' quality of life and increases the burden on family caregivers. Many patients struggle with self-care, including medication adherence, diet, and symptom monitoring.

The REMIND HF (REmote Motivational INterviewing for Disease Management in Heart Failure) study aims to evaluate the effectiveness of remote motivational interviewing (MI) as a behavioral intervention to improve disease management and self-care among heart failure patients and their informal caregivers. The intervention consists of a series of online motivational interviews conducted by trained nurses over a 12-month period, focusing on lifestyle modification, self-monitoring, and patient-caregiver cooperation.

The study will be conducted at the Wroclaw Medical University and collaborating centers. It will enroll 300 patients with heart failure (The New York Heart Association Functional Classificaion - NYHA class: II-IV) and their primary caregivers. Outcomes will include self-care behaviors, quality of life, psychological well-being, and health service utilization. The results will contribute to developing accessible, patient-centered models of heart failure management based on telehealth and behavioral support.

Eligibility criteria

Qualifiers

Adult patients aged 18 years or older.

Diagnosis of heart failure.

New York Heart Association (NYHA) functional class II-IV.

Poor self-care as assessed at baseline.

Disqualifiers

Severe cognitive impairment that would limit the ability to participate in the intervention or complete study assessments.

Acute coronary syndrome or other acute cardiac event within the last 3 months.

Residence in a nursing home or long-term care facility.

Inability to participate in videoconferencing sessions.

Trial design

Treatments tested in this trial

  • Remote Motivational Interviewing
  • Standard Heart Failure Care

Treatment groups

600 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Wroclaw Medical University

Lead sponsor

University of Rome Tor Vergata

Collaborator